Investors Capital Advisory Services’s GSK GSK Stock Holding History

Investors Capital Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$854K	Buy	15,768 +4,694	+42%	+$247K	0.16%	168
2016 Q1	$561K	Buy	11,074 +1,362	+14%	+$67.8K	0.11%	246
2015 Q4	$489K	Sell	9,712 -1,374	-12%	-$70K	0.1%	296
2015 Q3	$532K	Buy	11,086 +306	+3%	+$15.9K	0.11%	263
2015 Q2	$561K	Buy	10,780 +1,300	+14%	+$73.2K	0.1%	284
2015 Q1	$546K	Buy	9,480 +83	+0.9%	+$4.76K	0.1%	282
2014 Q4	$502K	Buy	9,397 +1,755	+23%	+$98.2K	0.1%	300
2014 Q3	$439K	Buy	7,642 +1,092	+17%	+$66.9K	0.09%	335
2014 Q2	$437K	Hold	6,550	–	–	0.07%	377
2014 Q1	$437K	Buy	6,550 +405	+7%	+$27.4K	0.09%	309
2013 Q4	$410K	Buy	6,145 +382	+7%	+$24.8K	0.1%	304
2013 Q3	$361K	Buy	5,763 +428	+8%	+$27.6K	0.09%	306
2013 Q2	$333K	Buy	+5,335	New	+$339K	0.1%	284

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Investors Capital Advisory Services's GSK Position: Q2 2016 in Review

Investors Capital Advisory Services increased its GSK (GSK) stake by 42% in Q2 2016, buying an estimated $247K and bringing the position to 15,768 shares worth $854K. The position accounts for 0.16% of the portfolio, ranked #168.

Investors Capital Advisory Services first reported a position in GSK in Q2 2013 and has held it in 13 quarters since. 741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

Investors Capital Advisory Services held 15,768 shares of GSK worth $854K as of Q2 2016.
Investors Capital Advisory Services bought 4,694 GSK shares in Q2 2016, an estimated $247K.
GSK made up 0.16% of Investors Capital Advisory Services's portfolio in Q2 2016, its #168 holding.
Investors Capital Advisory Services first reported a position in GSK in Q2 2013 and has held it in 13 quarters since.
741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.